|
Arcadia Biosciences, Inc. (RKDA) DCF -Bewertung
US | Basic Materials | Agricultural Inputs | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Arcadia Biosciences, Inc. (RKDA) Bundle
Entdecken Sie die finanziellen Aussichten von Arcadia Biosciences, Inc. (RKDA) mit unserem benutzerfreundlichen DCF-Taschenrechner! Geben Sie Ihre Annahmen in Bezug auf Wachstum, Margen und Kosten ein, um den inneren Wert von Arcadia Biosciences, Inc. (RKDA) zu berechnen und Ihre Anlagestrategie zu informieren.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.2 | 8.0 | 6.8 | 10.0 | 5.3 | 6.5 | 7.8 | 9.5 | 11.5 | 13.9 |
| Revenue Growth, % | 0 | 587.25 | -15.61 | 46.84 | -46.46 | 21.19 | 21.19 | 21.19 | 21.19 | 21.19 |
| EBITDA | -28.7 | -5.4 | -23.3 | -13.6 | -13.6 | -6.0 | -7.3 | -8.9 | -10.8 | -13.0 |
| EBITDA, % | -2452.69 | -67.72 | -343.17 | -137.07 | -254.75 | -93.54 | -93.54 | -93.54 | -93.54 | -93.54 |
| Depreciation | .2 | .7 | 1.0 | 1.4 | .3 | .8 | .9 | 1.1 | 1.4 | 1.7 |
| Depreciation, % | 16.6 | 8.24 | 15.41 | 13.69 | 5.38 | 11.86 | 11.86 | 11.86 | 11.86 | 11.86 |
| EBIT | -28.9 | -6.1 | -24.3 | -15.0 | -13.9 | -6.1 | -7.5 | -9.0 | -10.9 | -13.3 |
| EBIT, % | -2469.29 | -75.96 | -358.58 | -150.76 | -260.13 | -95.19 | -95.19 | -95.19 | -95.19 | -95.19 |
| Total Cash | 25.3 | 25.7 | 28.7 | 20.6 | 11.6 | 6.5 | 7.8 | 9.5 | 11.5 | 13.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .6 | 1.4 | 1.4 | 1.2 | .5 | 1.4 | 1.7 | 2.1 | 2.6 | 3.1 |
| Account Receivables, % | 51.5 | 17.5 | 20.21 | 12.26 | 9.64 | 22.22 | 22.22 | 22.22 | 22.22 | 22.22 |
| Inventories | 1.8 | 3.8 | 4.4 | 2.6 | 2.0 | 3.6 | 4.3 | 5.2 | 6.3 | 7.7 |
| Inventories, % | 153.46 | 47.45 | 65.38 | 25.82 | 36.74 | 55.08 | 55.08 | 55.08 | 55.08 | 55.08 |
| Accounts Payable | .5 | .7 | 1.4 | .9 | .8 | 1.2 | 1.5 | 1.8 | 2.2 | 2.7 |
| Accounts Payable, % | 42.09 | 9.04 | 20.81 | 9.09 | 15.03 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 |
| Capital Expenditure | -1.5 | -2.3 | -1.0 | -.1 | .0 | -1.9 | -2.3 | -2.7 | -3.3 | -4.0 |
| Capital Expenditure, % | -126.35 | -29.06 | -14.85 | -0.72318 | -0.09380863 | -28.95 | -28.95 | -28.95 | -28.95 | -28.95 |
| Tax Rate, % | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 |
| EBITAT | -28.9 | -6.0 | -24.3 | -15.0 | -14.7 | -6.1 | -7.4 | -9.0 | -10.9 | -13.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -32.1 | -10.2 | -24.2 | -12.2 | -13.2 | -9.3 | -9.6 | -11.6 | -14.0 | -17.0 |
| WACC, % | 7.48 | 7.47 | 7.48 | 7.48 | 7.48 | 7.48 | 7.48 | 7.48 | 7.48 | 7.48 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -48.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -17 | |||||||||
| Terminal Value | -317 | |||||||||
| Present Terminal Value | -221 | |||||||||
| Enterprise Value | -270 | |||||||||
| Net Debt | -6 | |||||||||
| Equity Value | -264 | |||||||||
| Diluted Shares Outstanding, MM | 1 | |||||||||
| Equity Value Per Share | -213.43 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real RKDA financials.
- Real-World Data: Historical data and forward-looking estimates (highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly visualize how your inputs affect Arcadia Biosciences’ valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive Data: Arcadia Biosciences’ historical financial statements and pre-filled projections.
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Results: Observe Arcadia Biosciences’ intrinsic value update instantly.
- Intuitive Visual Outputs: Dashboard graphs illustrate valuation outcomes and essential metrics.
- Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the prebuilt Excel template featuring Arcadia Biosciences, Inc.’s (RKDA) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalculated results, including Arcadia Biosciences, Inc.’s (RKDA) intrinsic value.
- Step 5: Make well-informed investment decisions or create reports based on the results.
Why Choose This Calculator for Arcadia Biosciences, Inc. (RKDA)?
- User-Friendly Interface: Perfect for both novice and experienced users.
- Customizable Inputs: Adjust parameters to fit your specific analysis needs.
- Real-Time Feedback: Watch as Arcadia’s valuation updates instantly with your changes.
- Pre-Loaded Data: Comes equipped with Arcadia’s latest financial information for immediate insights.
- Relied Upon by Experts: A go-to tool for investors and analysts aiming for informed decisions.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for analyzing portfolios related to Arcadia Biosciences, Inc. (RKDA).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Offer clients precise valuation insights for Arcadia Biosciences, Inc. (RKDA) stock.
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotechnology firms like Arcadia Biosciences, Inc. (RKDA) are valued in the market.
What the Template Contains
- Historical Data: Includes Arcadia Biosciences, Inc.’s past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Arcadia Biosciences, Inc.’s intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Arcadia Biosciences, Inc.’s financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.